Daniel Patrick O'Day, Director, Chairman & CEO, on April 28, 2026, sold 10,000 shares in Gilead Sciences (GILD) for $1,291,608. Following the Form 4 filing with the SEC, O'Day has control over a total of 632,567 common shares of the company, with 632,567 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/882095/000163864326000020/xslF345X05/wk-form4_1777499620.xml
James Edgemond, CFO and Treasurer, on April 27, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,688,319. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000163617826000013/xslF345X05/primarydocument.xml
Martin Roper, Director, Chief Executive Officer, on April 24, 2026, sold 50,000 shares in Vita Coco Company (COCO) for $2,500,000. Following the Form 4 filing with the SEC, Roper has control over a total of 987,577 common shares of the company, with 298,484 shares held directly and 689,093 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1482981/000148298126000114/xslF345X05/form4.xml
Russell Barrett, Senior Executive Vice President, Chief Operating Officer, on April 27, 2026, sold 90,537 shares in Valley National Bancorp (VLY) for $1,225,871. Following the Form 4 filing with the SEC, Barrett has control over a total of 64,167 common shares of the company, with 64,167 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/714310/000200688626000005/xslF345X05/wk-form4_1777410703.xml